Status:
NOT_YET_RECRUITING
Clinical Study of Active Intervention in High-risk HFpEF Patients
Lead Sponsor:
Xiangtan Central Hospital
Collaborating Sponsors:
The First People's Hospital of Xiangtan City
The Xiangtan People's Hospital
Conditions:
Heart Failure With Preserved Ejection Fraction
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Based on inclusion and exclusion criteria, this experiment plans to include 924 Heart Failure with Preserved Ejection Fraction(HFpEF) patients with increased risk of all-cause death. The enrolled pati...
Detailed Description
Our newly finished study developed and validated a risk prediction model for all-cause mortality in patients with HFpEF based on real-world data. The nomogram prediction model included factors such as...
Eligibility Criteria
Inclusion
- Discharged HFpEF patients with risk score \> or equal 200.37.
Exclusion
- Patients with a life expectancy of less than 1-year due to malignancy.
Key Trial Info
Start Date :
August 1 2024
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
August 1 2028
Estimated Enrollment :
924 Patients enrolled
Trial Details
Trial ID
NCT06532019
Start Date
August 1 2024
End Date
August 1 2028
Last Update
August 1 2024
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.